Eledon Pharmaceuticals Insider Trades
NASDAQ: ELDNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Eledon Pharmaceuticals insider activity
Over the last 12 months, Eledon Pharmaceuticals insiders reported 10 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Perrin Steven (President) reporting a transaction in 152,353 shares on Jul 31, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ELDN's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ELDN insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 31, 2026 | Gros David-Alexandre CChief Executive Officer | Tax withholding | 194,791 | $658.39K | Form 4 |
| Jul 31, 2026 | Gros David-Alexandre CChief Executive Officer | Award | 354,454 | — | Form 4 |
| Jul 31, 2026 | Perrin StevenPresident | Tax withholding | 72,138 | $243.83K | Form 4 |
| Jul 31, 2026 | Perrin StevenPresident | Award | 152,353 | — | Form 4 |
| Jan 10, 2026 | Lee JuneDirector | Option exercise | 3,430 | — | Form 4 |
| Jan 10, 2026 | Hillson JanDirector | Option exercise | 3,430 | — | Form 4 |
| Jan 10, 2026 | Robinson James A. Jr.Director | Option exercise | 3,430 | — | Form 4 |
| Jan 10, 2026 | McBride John S.Director | Option exercise | 3,430 | — | Form 4 |
| Jan 10, 2026 | Katkin KeithDirector | Option exercise | 8,575 | — | Form 4 |
| Jan 10, 2026 | Kirk AllanDirector | Option exercise | 3,430 | — | Form 4 |
| May 9, 2024 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BVF I GP LLC & BIOTECHNOLOGY VALUE FUND II LP & BVF II GP LLC & Biotechnology Value Trading Fund OS LP & BVF Partners OS Ltd. & BVF GP HOLDINGS LLC & BVF INC/IL & LAMPERT MARK N10% Owner | Buy | 75,431 | — | Form 4 |
| May 9, 2024 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BVF I GP LLC & BIOTECHNOLOGY VALUE FUND II LP & BVF II GP LLC & Biotechnology Value Trading Fund OS LP & BVF Partners OS Ltd. & BVF GP HOLDINGS LLC & BVF INC/IL & LAMPERT MARK N10% Owner | Buy | 821,121 | — | Form 4 |
| May 9, 2024 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BVF I GP LLC & BIOTECHNOLOGY VALUE FUND II LP & BVF II GP LLC & Biotechnology Value Trading Fund OS LP & BVF Partners OS Ltd. & BVF GP HOLDINGS LLC & BVF INC/IL & LAMPERT MARK N10% Owner | Buy | 1,031,385 | — | Form 4 |
| May 5, 2023 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BVF I GP LLC & BIOTECHNOLOGY VALUE FUND II LP & BVF II GP LLC & Biotechnology Value Trading Fund OS LP & BVF Partners OS Ltd. & BVF GP HOLDINGS LLC & BVF INC/IL & LAMPERT MARK N10% Owner | Buy | 86,341 | — | Form 4 |
| May 5, 2023 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BVF I GP LLC & BIOTECHNOLOGY VALUE FUND II LP & BVF II GP LLC & Biotechnology Value Trading Fund OS LP & BVF Partners OS Ltd. & BVF GP HOLDINGS LLC & BVF INC/IL & LAMPERT MARK N10% Owner | Buy | 837,146 | — | Form 4 |
| May 5, 2023 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BVF I GP LLC & BIOTECHNOLOGY VALUE FUND II LP & BVF II GP LLC & Biotechnology Value Trading Fund OS LP & BVF Partners OS Ltd. & BVF GP HOLDINGS LLC & BVF INC/IL & LAMPERT MARK N10% Owner | Buy | 1,055,445 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4